Danaher Corp
NYSE:DHR
Danaher Corp
NYSE:DHR
Price:
248.76 USD
0.55%
Market Closed
Updated:
May 8, 2024
Danaher Corp
Operating Income
|
Danaher Corp
Operating Income Peer Comparison
Comparables:
TMO
WST
MTD
A
IQV
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Danaher Corp
NYSE:DHR
|
Operating Income
$9.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
26%
|
CAGR 10-Years
12%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Operating Income
$7.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Operating Income
$661.6m
|
CAGR 3-Years
9%
|
CAGR 5-Years
20%
|
CAGR 10-Years
15%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Operating Income
$1.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Operating Income
$1.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
16%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Operating Income
$2.1B
|
CAGR 3-Years
38%
|
CAGR 5-Years
21%
|
CAGR 10-Years
16%
|
See Also
What is Danaher Corp's Operating Income?
Operating Income
9.5B
USD
9.5B
USD
Based on the financial report for Mar 29, 2024, Danaher Corp's Operating Income amounts to 9.5B USD.
What is Danaher Corp's Operating Income growth rate?
Operating Income CAGR 10Y
12%
12%
Over the last year, the Operating Income growth was 14%. The average annual Operating Income growth rates for Danaher Corp have been 20% over the past three years , 26% over the past five years , and 12% over the past ten years .
You don't have any saved screeners yet
